Abiopharma

TFI International publiera ses résultats du deuxième trimestre de 2026

Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database

Ampco-Pittsburgh Corporation Joins US small-cap Russell 2000® Index

Synchrony Announces Executive Leadership Changes to Advance Digital Growth, Customer Experience and AI Momentum

Results of Operations for the Three Months Ended March 31, 2026 - American Overseas Group Limited Announces Net Income Of $3.3 Million For the Three Months Ended March 31, 2026

PEOPLES BANCORP INC. TO ANNOUNCE 2ND QUARTER 2026 EARNINGS AND CONDUCT CONFERENCE CALL ON JULY 21, 2026

Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson’s Disease

Realty Income Prices €600 Million Euro-Denominated Senior Unsecured Notes Offering

Vantage Corp Issues Statement Regarding Recent Trading Activity

American Coastal Insurance Corporation Announces the Completion of $14.4 Million in Common Stock Share Repurchases